Mohammadi et al. paid the attention on the improvement of lipid accumulation by CA and fish oil through a NAFLD cell model via the AMPK-mediated SREBP-1/FAS and PPARα/UCP2 pathways [71]. The gene discussed is SREBF1; the disease is metabolic dysfunction-associated steatotic liver disease.